Company intelligence / Profile preview

Inovedis

Albstadt, Baden-Württemberg, Germany

Ownership: Private
Development stage: Other

Overview

SINEFIX received FDA clearance in July 2023 and was launched at selected clinical sites in the U.S. The system simplifies rotator cuff repair surgery through a staple-based implant that maintains blood circulation while providing mechanical fixation, designed to reduce surgery time and improve healing outcomes compared to traditional knot-and-anchor techniques.

Therapeutic areas: Other
Modalities: Device
Industry: Implantable Medical Devices

Partnerships

RENOLIT (strategic partner)

Beyond the preview

Go deeper on Inovedis.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Inovedis.

Explore the full profile